This review highlights recent progress in nanocarriers targeting pattern recognition receptors (PRRs), including Toll‐like and NOD‐like receptors, for enhancing the treatment of bacterial sepsis and related complications. These nanomedicines deliver antibiotics and anti‐inflammatory agents while modulating immune responses.
Eman A. Ismail+3 more
wiley +1 more source
Imaging pH in a live rabbit at the surface of a sensor‐coated titanium plate using X‐ray excited luminescent chemical imaging (XELCI). A raster scanning X‐ray beam generates radioluminescence from a spot on the sensor, and the luminescence passes through the tissue and is collected at two wavelengths to determine local pH.
Unaiza Uzair+6 more
wiley +1 more source
Vascular Diseases in Women: Do Women Suffer from Them Differently? [PDF]
Farkas K+15 more
europepmc +1 more source
An ex vivo glomerular filtration barrier is engineered using electrospun, biomimetic membranes seeded with human glomerular cells. The model supports fenestrated endothelium and podocyte foot processes under flow, mimics size‐selective filtration, and enables disease modeling with hiPSC‐derived podocytes, offering a powerful platform for studying ...
Camilla Mussoni+8 more
wiley +1 more source
Causal association between epigenetic age acceleration and two pulmonary vascular diseases: pulmonary arterial hypertension and pulmonary embolism-a bidirectional Mendelian study. [PDF]
Tong J+5 more
europepmc +1 more source
Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4+Foxp3+ Regulatory T Cell Immunosuppression. [PDF]
Shao Y+10 more
europepmc +1 more source
Exosomal noncoding RNA: A potential therapy for retinal vascular diseases. [PDF]
Heo JI, Ryu J.
europepmc +1 more source
Collaborative Vascular Research in Europe to Improve Care for Patients With Vascular Diseases: What Is Out There, and How to Participate? [PDF]
Lareyre F+2 more
europepmc +1 more source
PCSK9 genetic variants and risk of vascular and non-vascular diseases in Chinese and UK populations. [PDF]
Holmes MV+20 more
europepmc +1 more source
New Therapeutic Strategies in Retinal Vascular Diseases: A Lipid Target, Phosphatidylserine, and Annexin A5-A Future Theranostic Pairing in Ophthalmology. [PDF]
Frostegård A, Haegerstrand A.
europepmc +1 more source